SEC Form 4 · accession 0001209191-18-005366
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay Barth
Officer — Chief Medical Officer
Period of report
Jan 23, 2018
Accepted (ET)
Jan 25, 2018 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 23, 2018 | M | 20,000 | $2.29 | A | 105,409 | D | |
| Common Stock | Jan 23, 2018 | S | 20,000 | $16.80 | D | 85,409 | D | |
| Common Stock | holding | — | — | — | 125 | I | By Daughter |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F2 | $2.29 | Jan 23, 2018 | M | 20,000 | D | — | Mar 3, 2024 | Common Stock | 20,000 | 110,000 | D |
Explanation of responses
- F1The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017.
- F2These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vested on March 3, 2015. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on April 1, 2015, with the final installment vesting on March 1, 2018.